UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

Breast cancer research and treatment, 2016-12, Vol.160 (3), p.439-446

2016

Volltextzugriff (PDF)

Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy

Expert opinion on therapeutic targets, 2012-01, Vol.16 (1), p.103-119

2012

Volltextzugriff (PDF)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

International journal of molecular sciences, 2023-04, Vol.24 (8), p.6945

2023

Volltextzugriff (PDF)

A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients

Clinical cancer research, 2015-03, Vol.21 (5), p.1207-1214

2015

Volltextzugriff (PDF)

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

Current cancer drug targets, 2015-10, Vol.15 (8), p.665

2015

Volltextzugriff (PDF)

Gene Expression Profiling in Early Breast Cancer-Patient Stratification Based on Molecular and Tumor Microenvironment Features

Biomedicines, 2022-01, Vol.10 (2), p.248

2022

Volltextzugriff (PDF)

Prolyl‐isomerase Pin1 controls normal and cancer stem cells of the breast

EMBO molecular medicine, 2014-01, Vol.6 (1), p.99-119

2014

Volltextzugriff (PDF)

The Evolving Field of Tyrosine Kinase Inhibitors in the Treatment of Endocrine Tumors

Endocrine reviews, 2010-08, Vol.31 (4), p.578-599

2010

Volltextzugriff (PDF)

MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype

Endocrine-related cancer, 2010-03, Vol.17 (1), p.F51-F75

2010

Volltextzugriff (PDF)

Inhibition of RET activated pathways: novel strategies for therapeutic intervention in human cancers

Current pharmaceutical design, 2013-02, Vol.19 (5), p.864

2013

Volltextzugriff (PDF)

DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes

The oncologist (Dayton, Ohio), 2013, Vol.18 (10), p.1063-1073

2013

Volltextzugriff (PDF)

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.333-343

2012

Volltextzugriff (PDF)

Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma

International Journal of Endocrinology, 2013-01, Vol.2013, p.803171-16

2013

Volltextzugriff (PDF)

Genetic alterations in the RAS/RAF/mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma

Cancer, 2010-06, Vol.116 (12), p.2974-2983

2010

Volltextzugriff (PDF)

Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer

International journal of molecular sciences, 2017-01, Vol.18 (1), p.194-194

2017

Volltextzugriff (PDF)

Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer

Cytokine (Philadelphia, Pa.), 2012-08, Vol.59 (2), p.218-222

2012

Volltextzugriff (PDF)

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Breast cancer research : BCR, 2013-09, Vol.15 (5), p.R86-R86, Article R86

2013

Volltextzugriff (PDF)

Prognostic and Therapeutic Implications of Distinct Kinase Expression Patterns in Different Subtypes of Breast Cancer

Cancer research (Chicago, Ill.), 2010-11, Vol.70 (21), p.8852-8862

2010

Volltextzugriff (PDF)

Missense Mutation in the Transcription Factor NKX2–5: A Novel Molecular Event in the Pathogenesis of Thyroid Dysgenesis

The journal of clinical endocrinology and metabolism, 2006-04, Vol.91 (4), p.1428-1433

2006

Volltextzugriff (PDF)

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

Human pathology, 2009-06, Vol.40 (6), p.827-833

2009

Volltextzugriff (PDF)

Role of inflammation in obesity-related breast cancer

Current opinion in pharmacology, 2016-12, Vol.31, p.114-122

2016

Volltextzugriff (PDF)

Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification

Human pathology, 2008, Vol.39 (1), p.15-20

2008

Volltextzugriff (PDF)

Targeting microRNAs as key modulators of tumor immune response

Journal of experimental & clinical cancer research, 2016-06, Vol.35 (1), p.103-103, Article 103

2016

Volltextzugriff (PDF)

Breast cancer assessment tools and optimizing adjuvant therapy

Nature reviews. Clinical oncology, 2010-12, Vol.7 (12), p.725-732

2010

Volltextzugriff (PDF)

Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis

Journal of thoracic oncology, 2022-01, Vol.17 (1), p.103-115

2022

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(89)

Sprache

Englisch
(94)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Humans
(60)
Oncology
(38)
Female
(37)
Breast Cancer
(29)
Breast Neoplasms - Genetics
(17)
Biological And Medical Sciences
(15)
Breast Neoplasms - Drug Therapy
(15)
Breast Neoplasms - Pathology
(15)
Medical Sciences
(15)
Prognosis
(15)
Tumors
(15)
Adult
(13)
Endocrinology & Metabolism
(12)
Mutation
(12)
Breast Neoplasms - Metabolism
(10)
Cancer
(10)
Gene Expression Regulation, Neoplastic
(10)
Signal Transduction
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

Gene Expression Profiling in Early Breast Cancer-Patient Stratification Based on Molecular and Tumor Microenvironment Features

Prolyl‐isomerase Pin1 controls normal and cancer stem cells of the breast

The Evolving Field of Tyrosine Kinase Inhibitors in the Treatment of Endocrine Tumors

MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype

Inhibition of RET activated pathways: novel strategies for therapeutic intervention in human cancers

DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma

Genetic alterations in the RAS/RAF/mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma

Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer

Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Prognostic and Therapeutic Implications of Distinct Kinase Expression Patterns in Different Subtypes of Breast Cancer

Missense Mutation in the Transcription Factor NKX2–5: A Novel Molecular Event in the Pathogenesis of Thyroid Dysgenesis

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

Role of inflammation in obesity-related breast cancer

Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification

Targeting microRNAs as key modulators of tumor immune response

Breast cancer assessment tools and optimizing adjuvant therapy

Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis

Aktive Filter

Suchergebnisse filtern